Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

HealthLynked (HLYK) Receivables - Other (2021 - 2025)

HealthLynked (HLYK) has disclosed Receivables - Other for 5 consecutive years, with $10677.0 as the latest value for Q2 2025.

  • On a quarterly basis, Receivables - Other rose 29.2% to $10677.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $10677.0, a 29.2% increase, with the full-year FY2024 number at $20058.0, up 292.52% from a year prior.
  • Receivables - Other was $10677.0 for Q2 2025 at HealthLynked, down from $13913.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $1.9 million in Q1 2024 to a low of $5110.0 in Q4 2023.
  • A 5-year average of $385833.6 and a median of $20058.0 in 2024 define the central range for Receivables - Other.
  • Biggest YoY gain for Receivables - Other was 292.52% in 2024; the steepest drop was 99.27% in 2024.
  • HealthLynked's Receivables - Other stood at $300600.0 in 2021, then skyrocketed by 68.37% to $506110.0 in 2022, then crashed by 98.99% to $5110.0 in 2023, then surged by 292.52% to $20058.0 in 2024, then tumbled by 46.77% to $10677.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Receivables - Other are $10677.0 (Q2 2025), $13913.0 (Q1 2025), and $20058.0 (Q4 2024).